Mustang Bio, Inc. (MBIO): Cash & Equivalents
$17.27M
As of 2025-12-31
$15.15M
As of 2026-06-30
-38.9%
3-year compound annual growth
-29.3%
5-year compound annual growth
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $17.27M | +152.5% | 2026-03-19, Balance as of period end |
| 2024-12-31 | $6.84M | +9.7% | 2026-03-19, Balance as of period end |
| 2023-12-31 | $6.23M | -91.8% | 2025-03-28, Balance as of period end |
| 2022-12-31 | $75.66M | -31.0% | 2024-03-11, Balance as of period end |
| 2021-12-31 | $109.62M | +12.1% | 2023-03-30, Balance as of period end |
| 2020-12-31 | $97.80M | +59.3% | 2022-03-23, Balance as of period end |
| 2019-12-31 | $61.41M | +272.9% | 2021-03-24, Balance as of period end |
| 2018-12-31 | $16.47M | n/a | 2020-03-16, Balance as of period end |
Cash & Equivalents at similar companies
| Company | Year ended | Cash & Equivalents | Change YoY |
|---|---|---|---|
| Mustang Bio, Inc. (MBIO) | 2025-12-31 | $17.27M | +152.5% |
| Lisata Therapeutics, Inc. (LSTA) | 2025-12-31 | $15.96M | -1.6% |
| Impact Biomedical Inc. (IBO) | 2025-12-31 | $3.0K | -99.8% |
| Clene Inc. (CLNN) | 2025-12-31 | $5.19M | -57.3% |
| Lipocine Inc. (LPCN) | 2025-12-31 | $5.21M | -16.1% |
| Allarity Therapeutics, Inc. (ALLR) | 2025-12-31 | $14.69M | -24.8% |
| Tempest Therapeutics, Inc. (TPST) | 2025-12-31 | $7.71M | -74.5% |
| Galmed Pharmaceuticals Ltd. (EOCN) | 2025-12-31 | $3.98M | -14.3% |
| Aditxt, Inc. (ADTX) | 2024-12-31 | $833.0K | +757.9% |
Compare MBIO, LSTA, IBO, CLNN side by side · Screen every company in Pharmaceutical Preparations ↗